Authorizes visiting advanced practice nurses who are not certified by endorsement in New Jersey to engage in the limited practice of prescribing medications and devices, if they have appropriate educational qualifications.
A5068 would create a new category of “visiting advanced practice nurse” for nonresidents who are temporarily in New Jersey and are licensed or certified as advanced practice nurses in another state or jurisdiction, but who are not seeking full New Jersey certification by endorsement. The bill allows these visiting nurses to engage in the limited practice of prescribing medications and devices in New Jersey, so long as they meet educational and credentialing requirements and are approved by the New Jersey Board of Nursing.
The bill requires a visiting advanced practice nurse to give the Board of Nursing written notice at least 10 days before prescribing in the state. The notice must include the nurse’s qualifications, licenses, jurisdictions of licensure, training background, and intended timeframe of practice. The board must review the credentials within seven days, issue a visiting nurse identification number if the nurse is approved, or impose restrictions if the nurse’s authority or training is not substantially equivalent to New Jersey standards. The bill also authorizes the board to require skills assessments, additional training, supervision, or even prohibit prescribing in New Jersey if warranted.
The bill amends multiple sections of New Jersey’s nursing statutes to recognize visiting advanced practice nurses and to extend to them, in limited circumstances, the authority to prescribe medications and devices. It also directs the Board of Nursing and the Division of Consumer Affairs to establish standards and procedures for evaluating these out-of-state practitioners, and it updates related provisions governing joint protocols, controlled dangerous substances, continuing education, disciplinary authority, and record review. In practical terms, the measure affects advanced practice nurses, collaborating physicians, the Board of Nursing, and patients receiving care from temporary or traveling clinicians.
The bill text and available context suggest a generally supportive, administrative-regulatory approach rather than a controversial policy debate. Its stated purpose is to allow qualified visiting advanced practice nurses to practice more efficiently while preserving state oversight through notice, credential review, and prescribing restrictions. No committee transcripts or recorded votes were provided, so there is no documented floor or committee sentiment beyond the bill’s careful emphasis on qualification, supervision, and public protection.
The main point of potential contention is the balance between access and oversight: supporters would likely view the bill as improving flexibility for temporary or traveling advanced practice nurses and expanding patient access to care, while critics may worry about allowing non-New Jersey nurses to prescribe without full endorsement. The bill addresses that concern by requiring advance notice, board review, and the possibility of restrictions, skills assessments, or outright prohibition if the nurse’s training is not substantially equivalent. Another possible issue is the treatment of controlled dangerous substances, since the bill preserves collaboration and protocol requirements for those prescriptions.